Display options
Cite
Sales-Campos H, Tonani L, Cardoso CR, et al. The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection. Biomed Res Int. 2013;2013:693023doi: 10.1155/2013/693023.
Sales-Campos, H., Tonani, L., Cardoso, C. R., & Kress, M. R. (2013). The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection. BioMed research international, 2013693023. https://doi.org/10.1155/2013/693023
Sales-Campos, Helioswilton, et al. "The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection." BioMed research international vol. 2013 (2013): 693023. doi: https://doi.org/10.1155/2013/693023
Sales-Campos H, Tonani L, Cardoso CR, Kress MR. The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection. Biomed Res Int. 2013;2013:693023. doi: 10.1155/2013/693023. Epub 2013 Jul 30. PMID: 23984400; PMCID: PMC3745895.
Copy Download .nbib Format: NLM
Share it on

Biomed Res Int. 2013;2013:693023. doi: 10.1155/2013/693023. Epub 2013 Jul 30.

The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection.

BioMed research international

Helioswilton Sales-Campos, Ludmilla Tonani, Cristina Ribeiro Barros Cardoso, Márcia Regina Von Zeska Kress

Affiliations

  1. Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Avenida Do Café, 14040-903 Ribeirão Preto, SP, Brazil.

PMID: 23984400 PMCID: PMC3745895 DOI: 10.1155/2013/693023

Abstract

The interplay between Aspergillus fumigatus and the host immune response in lung infection has been subject of studies over the last years due to its importance in immunocompromised patients. The multifactorial virulence factors of A. fumigatus are related to the fungus biological characteristics, for example, structure, ability to grow and adapt to high temperatures and stress conditions, besides capability of evading the immune system and causing damage to the host. In this context, the fungus recognition by the host innate immunity occurs when the pathogen disrupts the natural and chemical barriers followed by the activation of acquired immunity. It seems clear that a Th1 response has a protective role, whereas Th2 reactions are often associated with higher fungal burden, and Th17 response is still controversial. Furthermore, a fine regulation of the effector immunity is required to avoid excessive tissue damage associated with fungal clearance, and this role could be attributed to regulatory T cells. Finally, in this work we reviewed the aspects involved in the complex interplay between the host immune response and the pathogen virulence factors, highlighting the immunological issues and the importance of its better understanding to the development of novel therapeutic approaches for invasive lung aspergillosis.

References

  1. Fungal Genet Biol. 2011 Jan;48(1):15-22 - PubMed
  2. Blood. 2012 Jan 26;119(4):967-77 - PubMed
  3. Infect Immun. 2011 Jan;79(1):125-35 - PubMed
  4. Appl Environ Microbiol. 2009 Jan;75(2):493-503 - PubMed
  5. Nature. 2009 Aug 27;460(7259):1117-21 - PubMed
  6. Mol Microbiol. 2009 Apr;72(1):155-69 - PubMed
  7. Med Mycol. 2005 May;43 Suppl 1:S87-93 - PubMed
  8. Clin Infect Dis. 2003 Jul 15;37(2):221-9 - PubMed
  9. Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3089-96 - PubMed
  10. Antimicrob Agents Chemother. 2007 Aug;51(8):2979-81 - PubMed
  11. PLoS Pathog. 2009 Oct;5(10):e1000639 - PubMed
  12. Blood. 2006 Mar 15;107(6):2562-9 - PubMed
  13. Int J Ophthalmol. 2012;5(4):409-14 - PubMed
  14. Thorax. 1952 Dec;7(4):317-33 - PubMed
  15. Microbiol Mol Biol Rev. 2000 Dec;64(4):746-85 - PubMed
  16. Med Microbiol Immunol. 1998 Oct;187(2):79-89 - PubMed
  17. Eukaryot Cell. 2008 Jul;7(7):1085-97 - PubMed
  18. Mol Microbiol. 2011 Oct;82(1):39-53 - PubMed
  19. Clin Diagn Lab Immunol. 1996 Nov;3(6):740-5 - PubMed
  20. Fungal Genet Biol. 2006 May;43(5):366-75 - PubMed
  21. Nature. 2002 Mar 14;416(6877):194-9 - PubMed
  22. Nature. 2001 May 31;411(6837):603-6 - PubMed
  23. Front Microbiol. 2012 Nov 06;3:381 - PubMed
  24. Blood. 2009 Sep 24;114(13):2619-22 - PubMed
  25. FEBS J. 2006 Jul;273(13):3038-53 - PubMed
  26. Infect Immun. 2008 May;76(5):2123-9 - PubMed
  27. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):373-80 - PubMed
  28. Nat Rev Microbiol. 2005 Dec;3(12):937-47 - PubMed
  29. Infect Immun. 2003 Jun;71(6):3551-62 - PubMed
  30. Microbiology (Reading). 2006 Jul;152(Pt 7):1919-1928 - PubMed
  31. Eukaryot Cell. 2008 Oct;7(10):1661-73 - PubMed
  32. Biol Lett. 2007 Oct 22;3(5):523-5 - PubMed
  33. Intern Med. 2000 Mar;39(3):209-12 - PubMed
  34. Int J Ophthalmol. 2013;6(1):30-3 - PubMed
  35. PLoS Pathog. 2008 Sep 12;4(9):e1000154 - PubMed
  36. Appl Microbiol Biotechnol. 2013 Feb;97(3):939-55 - PubMed
  37. J Bacteriol. 1998 Jun;180(12):3031-8 - PubMed
  38. Infect Immun. 2005 Sep;73(9):5493-503 - PubMed
  39. Allergy. 2004 Feb;59(2):198-203 - PubMed
  40. J Exp Med. 2005 Jan 17;201(2):233-40 - PubMed
  41. J Immunol. 2009 Apr 1;182(7):4306-12 - PubMed
  42. J Infect Dis. 1998 Aug;178(2):488-96 - PubMed
  43. Chest. 2002 Jun;121(6):1988-99 - PubMed
  44. Cell Host Microbe. 2009 Nov 19;6(5):470-81 - PubMed
  45. Infect Immun. 2006 Apr;74(4):2353-65 - PubMed
  46. Am J Respir Crit Care Med. 2004 Sep 15;170(6):621-5 - PubMed
  47. Mol Microbiol. 2008 Mar;67(6):1274-91 - PubMed
  48. Clin Diagn Lab Immunol. 2001 Nov;8(6):1240-7 - PubMed
  49. Eukaryot Cell. 2012 Aug;11(8):966-77 - PubMed
  50. Blood. 1990 Jan 15;75(2):350-6 - PubMed
  51. Mol Microbiol. 2005 Jun;56(6):1675-88 - PubMed
  52. Infect Immun. 2000 Jun;68(6):3736-9 - PubMed
  53. Genetics. 1969 Oct;63(2):317-27 - PubMed
  54. J Med Microbiol. 2004 Mar;53(Pt 3):175-181 - PubMed
  55. J Biol Chem. 2000 Sep 8;275(36):27594-607 - PubMed
  56. Mol Microbiol. 2007 May;64(4):1014-27 - PubMed
  57. Br Med J. 1953 Apr 25;1(4816):918-9 - PubMed
  58. J Clin Invest. 1982 Mar;69(3):617-31 - PubMed
  59. PLoS One. 2013;8(2):e56651 - PubMed
  60. Biol Cell. 1993;77(2):201-8 - PubMed
  61. Appl Environ Microbiol. 2010 Jun;76(12):3989-98 - PubMed
  62. Curr Opin Microbiol. 2009 Aug;12(4):377-83 - PubMed
  63. EMBO J. 2007 Jul 11;26(13):3157-68 - PubMed
  64. Int J Med Microbiol. 2011 Jun;301(5):400-7 - PubMed
  65. Cell Microbiol. 2002 Dec;4(12):793-803 - PubMed
  66. Blood. 2005 Dec 15;106(13):4397-406 - PubMed
  67. Infect Immun. 1997 Feb;65(2):564-70 - PubMed
  68. Chest. 1997 Aug;112(2):541-8 - PubMed
  69. Eukaryot Cell. 2005 Dec;4(12):1982-9 - PubMed
  70. Infect Immun. 2003 Jun;71(6):3034-42 - PubMed
  71. J Clin Invest. 2011 Nov;121(11):4420-32 - PubMed
  72. Eur J Immunol. 2007 Oct;37(10):2695-706 - PubMed
  73. Clin Infect Dis. 2008 Feb 1;46(3):327-60 - PubMed
  74. Mol Microbiol. 2004 May;52(3):785-99 - PubMed
  75. PLoS Pathog. 2011 Oct;7(10):e1002330 - PubMed
  76. Infect Immun. 2012 Apr;80(4):1424-36 - PubMed
  77. Biochem J. 1996 Jul 1;317 ( Pt 1):141-5 - PubMed
  78. Med Mycol. 2006 Sep;44 Suppl 1:S77-81 - PubMed
  79. Infect Immun. 2001 Apr;69(4):2402-6 - PubMed
  80. J Biol Chem. 2004 Aug 27;279(35):36426-32 - PubMed
  81. J Biol Chem. 2000 Dec 29;275(52):41528 - PubMed
  82. Clin Infect Dis. 2007 Nov 1;45(9):1161-70 - PubMed
  83. Mol Microbiol. 1996 May;20(3):667-79 - PubMed
  84. Mol Microbiol. 2008 Oct;70(1):27-43 - PubMed
  85. Bioessays. 2002 Oct;24(10):894-903 - PubMed
  86. Eukaryot Cell. 2005 Sep;4(9):1574-82 - PubMed
  87. Science. 2004 Mar 5;303(5663):1532-5 - PubMed
  88. PLoS Pathog. 2008 Nov;4(11):e1000200 - PubMed
  89. J Immunol. 2004 Dec 15;173(12):7406-15 - PubMed
  90. Infect Immun. 1995 Sep;63(9):3266-71 - PubMed
  91. Eur J Clin Microbiol Infect Dis. 2003 Aug;22(8):457-62 - PubMed
  92. J Clin Invest. 1996 May 15;97(10):2324-31 - PubMed
  93. J Immunol. 2011 Aug 1;187(3):1369-76 - PubMed
  94. J Immunol. 2009 Apr 15;182(8):4938-46 - PubMed
  95. Clin Allergy. 1976 May;6(3):209-17 - PubMed
  96. Eukaryot Cell. 2004 Apr;3(2):527-35 - PubMed
  97. J Clin Invest. 2010 Sep;120(9):3242-54 - PubMed
  98. Clin Infect Dis. 1998 Apr;26(4):781-803; quiz 804-5 - PubMed
  99. PLoS One. 2011 Jan 14;6(1):e16016 - PubMed
  100. PLoS Genet. 2011 Dec;7(12):e1002374 - PubMed
  101. Infect Immun. 2003 May;71(5):2819-26 - PubMed
  102. Radiology. 1981 Aug;140(2):313-21 - PubMed
  103. Front Microbiol. 2012 Feb 06;3:28 - PubMed
  104. Infect Immun. 2004 Aug;72(8):4731-40 - PubMed
  105. PLoS Pathog. 2010 Sep 30;6(9):e1001124 - PubMed
  106. Biochem Biophys Res Commun. 2003 Nov 28;311(4):1151-7 - PubMed
  107. Infect Immun. 2011 Nov;79(11):4459-71 - PubMed
  108. PLoS One. 2010 Feb 17;5(2):e9036 - PubMed
  109. Infect Immun. 2005 Aug;73(8):4548-59 - PubMed
  110. Mol Microbiol. 2000 Jun;36(6):1371-80 - PubMed
  111. Eur Respir J. 2003 Apr;21(4):582-8 - PubMed
  112. J Biol Chem. 2003 Mar 14;278(11):8869-72 - PubMed
  113. Microbes Infect. 2010 Nov;12(12-13):928-36 - PubMed
  114. Med Mycol. 2009;47 Suppl 1:S97-103 - PubMed
  115. Eukaryot Cell. 2008 Aug;7(8):1268-77 - PubMed
  116. Infect Dis Clin North Am. 2006 Sep;20(3):545-61, vi - PubMed
  117. PLoS One. 2011 Apr 13;6(4):e18777 - PubMed
  118. Clin Infect Dis. 2003 Oct 1;37 Suppl 3:S225-64 - PubMed
  119. J Hosp Infect. 2006 Jan;62(1):22-8 - PubMed
  120. Med Mycol. 2005 May;43 Suppl 1:S15-22 - PubMed
  121. J Infect Dis. 2012 Mar 15;205(6):944-54 - PubMed
  122. PLoS Pathog. 2007 Sep 28;3(9):1195-207 - PubMed
  123. J Allergy Clin Immunol. 2011 May;127(5):1243-52.e7 - PubMed
  124. J Infect Dis. 2003 Jul 15;188(2):320-6 - PubMed
  125. Eukaryot Cell. 2012 Apr;11(4):518-31 - PubMed
  126. J Infect Dis. 2009 Aug 15;200(4):647-56 - PubMed
  127. J Allergy Clin Immunol. 1988 Apr;81(4):718-25 - PubMed
  128. Int J Biochem Cell Biol. 2012 May;44(5):709-13 - PubMed
  129. Mol Microbiol. 2010 Nov;78(4):1038-54 - PubMed
  130. Infect Immun. 2012 Jan;80(1):429-40 - PubMed
  131. Inflamm Res. 2012 Jun;61(6):643-8 - PubMed
  132. Cell Microbiol. 2010 Apr 1;12(4):473-88 - PubMed
  133. J Med Microbiol. 2009 Jan;58(Pt 1):49-58 - PubMed
  134. Clin Microbiol Rev. 1999 Apr;12(2):310-50 - PubMed
  135. J Immunol. 2006 Feb 1;176(3):1712-23 - PubMed
  136. Antimicrob Agents Chemother. 2009 Feb;53(2):476-82 - PubMed
  137. Infect Immun. 2012 Jan;80(1):388-97 - PubMed
  138. Fungal Genet Biol. 2007 Mar;44(3):219-30 - PubMed
  139. FEMS Immunol Med Microbiol. 2004 Oct 1;42(2):155-66 - PubMed
  140. J Exp Med. 2004 Nov 1;200(9):1213-9 - PubMed
  141. Front Microbiol. 2010 Nov 11;1:125 - PubMed
  142. Infect Immun. 2003 Feb;71(2):891-903 - PubMed
  143. Infect Immun. 2004 Sep;72(9):5193-203 - PubMed
  144. J Cell Biol. 2007 Jan 15;176(2):231-41 - PubMed
  145. PLoS One. 2008 Jul 09;3(7):e2655 - PubMed
  146. Arch Microbiol. 2006 Nov;186(5):345-55 - PubMed
  147. J Clin Invest. 2003 Dec;112(12):1862-70 - PubMed
  148. BMC Microbiol. 2008 Jun 18;8:97 - PubMed
  149. Eukaryot Cell. 2006 Jul;5(7):1091-103 - PubMed
  150. Mol Microbiol. 2012 Apr;84(2):383-99 - PubMed
  151. Infect Immun. 2008 Mar;76(3):952-8 - PubMed
  152. J Immunol. 2009 Aug 15;183(4):2407-14 - PubMed
  153. J Immunol. 2009 Aug 15;183(4):2678-87 - PubMed
  154. Infect Immun. 2006 Aug;74(8):4865-74 - PubMed
  155. Cell Microbiol. 2010 Jul;12(7):863-72 - PubMed
  156. J Biol Chem. 2002 Oct 18;277(42):39320-6 - PubMed
  157. Infect Immun. 1997 Apr;65(4):1510-4 - PubMed
  158. Biol Chem Hoppe Seyler. 1992 Jul;373(7):529-46 - PubMed
  159. Eur Respir J. 2012 Feb;39(2):411-8 - PubMed
  160. Infect Immun. 2010 Aug;78(8):3585-94 - PubMed
  161. PLoS Pathog. 2010 Apr 29;6(4):e1000873 - PubMed
  162. Eukaryot Cell. 2010 Oct;9(10):1432-40 - PubMed
  163. Mol Microbiol. 2007 Jun;64(5):1182-97 - PubMed

Substances

MeSH terms

Publication Types